Mega Lifesciences PCL (BKK:MEGA)

Revenue by Segment

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Brands	8.74B	8.38B	8.01B	8.06B	6.91B
Original Equipment Manufacture (OEM)	312.44M	306.21M	279.62M	314.11M	320.63M
Distribution	5.13B	6.68B	7.41B	7.34B	6.93B
Unallocated Other Income	21.29M	17.69M	10.86M	13.65M	10.99M
Total	14.19B	15.39B	15.72B	15.73B	14.17B

Revenue by Geography

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Southeast Asia	11.83B	13.23B	13.76B	13.69B	12.25B
Others	1.24B	1.20B	964.88M	1.04B	1.04B
Africa	1.07B	913.40M	960.95M	948.87M	845.19M
Total	14.15B	15.34B	15.68B	15.69B	14.14B

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 13, 2026

Data Sources Report a data error